vTv Therapeutics

vTv Therapeutics VTVT Stock

$15.51   -5.195602%
Add to favorites
Market Cap
$62.22M
LOW - HIGH [24H]
$15.47 - $16.47
VOLUME [24H]
$10.59K
P/E Ratio
0
Earnings per share
-$0.44
ISIN
US9183852048
Price   Prediction

vTv Therapeutics Price Chart

Sorry, that's all we've gotfor now...

vTv Therapeutics (VTVT) stock price today is 15.51 USD on Tech Market Small (-5.2% on the day). Updated .

vTv Therapeutics VTVT Financial and Trading Overview

vTv Therapeutics stock price 15.51 USD
Previous Close 16.36 USD
Open 15.96 USD
Bid 20.9 USD x 500
Ask 16.27 USD x 100
Day's Range 15.47 - 16.47 USD
52 Week Range 15.47 - 44 USD
Volume 10.59K USD
Avg. Volume 33.32K USD
Market Cap 62.22M USD
Beta (5Y Monthly) 0.26
PE Ratio (TTM) N/A
EPS (TTM) -0.44 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 56 USD

VTVT Valuation Measures

Enterprise Value 115.83M USD
Trailing P/E N/A
Forward P/E -4.0060234
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.689052
Price/Book (mrq) 2.7696428
Enterprise Value/Revenue 3.144
Enterprise Value/EBITDA -10.556

Trading Information

vTv Therapeutics Stock Price History

Beta (5Y Monthly) 0.26
52-Week Change -44.65%
S&P500 52-Week Change 8.67%
52 Week High 44 USD
52 Week Low 15.47 USD
50-Day Moving Average 26.77 USD
200-Day Moving Average 32.47 USD

VTVT Share Statistics

Avg. Volume (3 month) 33.32K USD
Avg. Daily Volume (10-Days) 23.94K USD
Shares Outstanding 4.01M
Float 2.22M
Short Ratio 6.58
% Held by Insiders 38.27%
% Held by Institutions 42.17%
Shares Short 145.42K
Short % of Float 5.91%
Short % of Shares Outstanding 3.62%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:40

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -20.84%
Operating Margin (ttm) -29.79%
Gross Margin 20.77%
EBITDA Margin -29.78%

Management Effectiveness

Return on Assets (ttm) -7.70%
Return on Equity (ttm) -10.95%

Income Statement

Revenue (ttm) 36.84M USD
Revenue Per Share (ttm) 2.97 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 7.65M USD
EBITDA -10973000 USD
Net Income Avi to Common (ttm) -7678000 USD
Diluted EPS (ttm) -0.44
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 77.16M USD
Total Cash Per Share (mrq) 6.2 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 11.191
Book Value Per Share (mrq) 5.6

Cash Flow Statement

Operating Cash Flow (ttm) -21728000 USD
Levered Free Cash Flow (ttm) -4018875 USD

Profile of vTv Therapeutics

Country United States
State NC
City High Point
Address 3980 Premier Drive
ZIP 27265
Phone 336 841 0300
Website https://vtvtherapeutics.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 26

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.

Q&A For vTv Therapeutics Stock

What is a current VTVT stock price?

vTv Therapeutics VTVT stock price today per share is 15.51 USD.

How to purchase vTv Therapeutics stock?

You can buy VTVT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for vTv Therapeutics?

The stock symbol or ticker of vTv Therapeutics is VTVT.

Which industry does the vTv Therapeutics company belong to?

The vTv Therapeutics industry is Biotechnology.

How many shares does vTv Therapeutics have in circulation?

The max supply of vTv Therapeutics shares is 4.01M.

What is vTv Therapeutics Price to Earnings Ratio (PE Ratio)?

vTv Therapeutics PE Ratio is now.

What was vTv Therapeutics earnings per share over the trailing 12 months (TTM)?

vTv Therapeutics EPS is -0.44 USD over the trailing 12 months.

Which sector does the vTv Therapeutics company belong to?

The vTv Therapeutics sector is Healthcare.

vTv Therapeutics VTVT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Capital Market Composite RCMP US 100.96 USD —
-4.6
— — 100.89 USD — 105.64 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us US Tech Composite Total Return XCMP US 27958.09 USD —
-5.28
— — 27828.65 USD — 29466.09 USD — — — —
$2.09T
Total marketcap
$110.95B
Total volume
BTC 57.95%   •   ETH 9.84%
Dominance
Select currency